HOOKIPA PHARMA INC's ticker is HOOK and the CUSIP is 43906K100. A total of 75 filers reported holding HOOKIPA PHARMA INC in Q1 2022. The put-call ratio across all filers is 1.35 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $98,677 | -33.7% | 160,190 | -5.3% | 0.00% | – |
Q2 2023 | $148,873 | +41.6% | 169,174 | +18.5% | 0.00% | – |
Q1 2023 | $105,106 | -54.6% | 142,807 | -50.0% | 0.00% | – |
Q4 2022 | $231,348 | -1.1% | 285,614 | +63.5% | 0.00% | – |
Q3 2022 | $234,000 | -17.6% | 174,690 | +0.3% | 0.00% | – |
Q2 2022 | $284,000 | -70.9% | 174,125 | -59.4% | 0.00% | – |
Q1 2022 | $977,000 | +26.6% | 428,534 | +29.3% | 0.00% | – |
Q4 2021 | $772,000 | -63.7% | 331,477 | -8.1% | 0.00% | – |
Q3 2021 | $2,125,000 | -28.8% | 360,771 | +10.7% | 0.00% | – |
Q2 2021 | $2,986,000 | +12.8% | 326,012 | +65.7% | 0.00% | – |
Q1 2021 | $2,647,000 | +19.4% | 196,798 | -1.5% | 0.00% | – |
Q4 2020 | $2,216,000 | +16.5% | 199,827 | -0.5% | 0.00% | – |
Q3 2020 | $1,902,000 | -15.1% | 200,807 | +4.2% | 0.00% | – |
Q2 2020 | $2,239,000 | +129.9% | 192,722 | +63.3% | 0.00% | – |
Q1 2020 | $974,000 | -14.0% | 118,011 | +27.3% | 0.00% | – |
Q4 2019 | $1,133,000 | +522.5% | 92,668 | +282.9% | 0.00% | – |
Q3 2019 | $182,000 | +35.8% | 24,203 | -1.4% | 0.00% | – |
Q2 2019 | $134,000 | – | 24,536 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Redmile Group, LLC | 1,842,902 | $17,452,000 | 0.32% |
Samsara BioCapital, LLC | 116,602 | $1,104,000 | 0.31% |
Artal Group S.A. | 599,616 | $5,678,000 | 0.14% |
HHLR ADVISORS, LTD. | 943,254 | $8,933,000 | 0.07% |
DAFNA Capital Management LLC | 22,061 | $209,000 | 0.07% |
Baker Brothers Advisors | 700,481 | $6,634,000 | 0.03% |
ZACKS INVESTMENT MANAGEMENT | 72,064 | $682,000 | 0.01% |
HOWLAND CAPITAL MANAGEMENT LLC | 14,728 | $139,000 | 0.01% |
ETF MANAGERS GROUP, LLC | 14,374 | $139,000 | 0.00% |
Squarepoint Ops LLC | 12,699 | $120,000 | 0.00% |